Single Agent Abraxane as Second Line Therapy in Bladder Cancer

Clinical trial NCT00683059 · COMPLETED

Trial details

NCT number: NCT00683059
Sponsor: Sunnybrook Health Sciences Centre
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transitional Cell Carcinoma

Start date: 2008-03-01
Primary completion: 2012-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.